PARP inhibitor combined with platinum activates the cGAS-STING pathway to enhance anti-PD-L1 immunotherapy in lung adenocarcinoma

International Immunopharmacology 2026

View at publisher

Authors: Yanqi Feng, Zimin Han, Xinyue Liu, Shuxi Yao, Yiming Li, Yuelin Han, Shu Xia

DOI: 10.1016/j.intimp.2026.116325

Cited by: 2

References: 47

Fields of Study & Subjects

interferon and immune responses Cancer Immunotherapy and Biomarkers Ferroptosis and cancer prognosis

References 47